Molecular determinants of antibody-mediated priming to enhance detection of ctDNA

Low concentration of ctDNA limits the sensitivity of liquid biopsies in many applications. This study shows how engineered antibodies and other dsDNA-binding molecules can inhibit clearance of ctDNA from the bloodstream and increase concentration of ctDNA in a blood draw, and identifies the key features that enable this activity. Modulation of cfDNA in the bloodstream using these agents can increase recovery of ctDNA and improve the performance of liquid biopsies for cancer detection.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-01-29
DOI
https://doi.org/10.64898/2026.01.27.701975
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular determinants of antibody-mediated priming to enhance detection of ctDNA

Viktor A. Adalsteinsson, Timothy Blewett, Daniel M. Kim, Kasturi Chakraborty et al.
bioRxiv (Cold Spring Harbor Laboratory)
Monoclonal and Polyclonal Antibodies Research
article

Molecular determinants of antibody-mediated priming to enhance detection of ctDNA

Viktor A. Adalsteinsson, Timothy Blewett, Daniel M. Kim, Kasturi Chakraborty, Shervin Tabrizi, Savan K. Patel, Ruolin Liu, Carmen Martin-Alonso, Justin Rhoades, Andjela Crnjac, Sahil Patel, Claire Sullivan, J. Christopher Love, Zhenyi An, Sangeeta N. Bhatia, Lily Gao, Kan Xiong
article en

Abstract

Low concentration of ctDNA limits the sensitivity of liquid biopsies in many applications. This study shows how engineered antibodies and other dsDNA-binding molecules can inhibit clearance of ctDNA from the bloodstream and increase concentration of ctDNA in a blood draw, and identifies the key features that enable this activity. Modulation of cfDNA in the bloodstream using these agents can increase recovery of ctDNA and improve the performance of liquid biopsies for cancer detection.

bioRxiv (Cold Spring Harbor Laboratory)
Broad Institute (US), Boston University (US), University of Southern California (US), Biogen (United States) (US), Howard Hughes Medical Institute (US), Harvard University (US), Harvard–MIT Division of Health Sciences and Technology (US), Exact Sciences (United States) (US), Mass General Brigham (US), Massachusetts Institute of Technology (US), University of Pennsylvania (US)
Prostate Cancer Foundation, Massachusetts General Hospital, Dana-Farber/Harvard Cancer Center, Gerstner Family Foundation, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, National Institutes of Health, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 74%
Monoclonal and Polyclonal Antibodies Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.